Arrowhead Pharmaceuticals In – Investors and Politicians Who Own It
ARWR, 2 share classes and securities
Investors who own it
8 tracked investors, $1.1B in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Behzad AghazadehAvoro Capital Advisors, Q2 2026 | $925.6M | 8.31% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $162.4M | 0.81% |
Howard MarksBondOaktree Capital Management, Q2 2026 | $11M | 0.15% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $5.7M | 0.26% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $4.8M | 0.01% |
Daniel SchneebergerBondADAR1 Capital Management, Q2 2026 | $1.2M | 0.05% |
Polen CapitalQ2 2026 | $538.9K | 0.00% |
Barry RitholtzRitholtz Wealth Management, Q2 2026 | $324.2K | 0.00% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Behzad Aghazadeh | Added +2.8% | 10,900,000 |
| David Greenspan | Reduced −4.8% | 4,982,000 |
| Julian i Felix Baker | Added +78% | 1,670,762 |
| Daniel Schneeberger | Reduced −9.8% | 49,800 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
| Politician | Action | Traded |
|---|---|---|
Daniel S. GoldmanD-NY · House | Sold$1K–$15K | Jan 31, 2023disclosed Feb 24, 2023 |